Rongfeng Liu

568 total citations
32 papers, 382 citations indexed

About

Rongfeng Liu is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Rongfeng Liu has authored 32 papers receiving a total of 382 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 6 papers in Oncology and 5 papers in Cancer Research. Recurrent topics in Rongfeng Liu's work include Cancer-related gene regulation (5 papers), Epigenetics and DNA Methylation (5 papers) and Protein Degradation and Inhibitors (5 papers). Rongfeng Liu is often cited by papers focused on Cancer-related gene regulation (5 papers), Epigenetics and DNA Methylation (5 papers) and Protein Degradation and Inhibitors (5 papers). Rongfeng Liu collaborates with scholars based in China, Japan and South Korea. Rongfeng Liu's co-authors include Cheng Luo, Hualiang Jiang, Zhe Shi, Mingyue Zheng, Yu‐Chih Liu, Yu‐Chih Liu, Xuehong Zhang, Kaixian Chen, Daojing Zhang and Tian Li and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and International Journal of Molecular Sciences.

In The Last Decade

Rongfeng Liu

30 papers receiving 377 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rongfeng Liu China 13 270 37 37 35 35 32 382
Vivek Kumar Singh India 12 304 1.1× 22 0.6× 47 1.3× 44 1.3× 76 2.2× 20 489
Junichi Taira Japan 12 210 0.8× 22 0.6× 37 1.0× 25 0.7× 9 0.3× 40 360
Meijuan Huang China 12 157 0.6× 29 0.8× 46 1.2× 15 0.4× 132 3.8× 34 389
Xiuhua Wu China 10 230 0.9× 16 0.4× 46 1.2× 28 0.8× 62 1.8× 11 442
Byung Ju Kim Canada 10 198 0.7× 13 0.4× 46 1.2× 33 0.9× 19 0.5× 14 326
José Navarro‐Fernández Spain 16 311 1.2× 61 1.6× 39 1.1× 22 0.6× 172 4.9× 28 583
Dexuan Yang China 9 176 0.7× 14 0.4× 71 1.9× 12 0.3× 10 0.3× 15 328
Carina Danchik United States 8 183 0.7× 11 0.3× 52 1.4× 19 0.5× 7 0.2× 14 325
Ana Marı́a Zarate Chile 11 127 0.5× 15 0.4× 64 1.7× 11 0.3× 9 0.3× 29 329
Michael Plewe United States 10 384 1.4× 12 0.3× 94 2.5× 14 0.4× 33 0.9× 16 510

Countries citing papers authored by Rongfeng Liu

Since Specialization
Citations

This map shows the geographic impact of Rongfeng Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rongfeng Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rongfeng Liu more than expected).

Fields of papers citing papers by Rongfeng Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rongfeng Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rongfeng Liu. The network helps show where Rongfeng Liu may publish in the future.

Co-authorship network of co-authors of Rongfeng Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Rongfeng Liu. A scholar is included among the top collaborators of Rongfeng Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rongfeng Liu. Rongfeng Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lin, Chuan, et al.. (2025). Underwater dam crack image enhancement and crack detection based on improved diffusion model and SDI-ASF-YOLO11. Construction and Building Materials. 492. 142861–142861. 3 indexed citations
2.
Liu, Rongfeng, Yan Liu, Pengfei Xu, et al.. (2025). Forsythoside B and Its Derivatives as Novel ASGR1 Inhibitors for Enhanced Cholesterol Efflux. Chemistry & Biodiversity. 22(12). e01119–e01119. 1 indexed citations
3.
Zhao, Yiran, et al.. (2025). Genome-wide Characterization of the MBF1 Gene Family and Its Expression Pattern in Different Tissues and Under Stresses in Medicago truncatula and Medicago sativa. International Journal of Molecular Sciences. 26(2). 455–455. 1 indexed citations
4.
Liu, Rongfeng, et al.. (2024). The GJB3 correlates with the prognosis, immune cell infiltration, and therapeutic responses in lung adenocarcinoma. Open Medicine. 19(1). 20240974–20240974. 1 indexed citations
5.
Shi, Zhe, Rongfeng Liu, Qingqing Zhu, et al.. (2023). D‐1553: A novel KRASG12C inhibitor with potent and selective cellular and in vivo antitumor activity. Cancer Science. 114(7). 2951–2960. 22 indexed citations
6.
Zhang, Xia & Rongfeng Liu. (2023). Pyroptosis-related genes GSDMB, GSDMC, and AIM2 polymorphisms are associated with risk of non-small cell lung cancer in a Chinese Han population. Frontiers in Genetics. 14. 1212465–1212465. 2 indexed citations
7.
8.
Xu, Yanzhao, et al.. (2021). Epigenetic Study of Esophageal Carcinoma Based on Methylation, Gene Integration and Weighted Correlation Network Analysis. OncoTargets and Therapy. Volume 14. 3133–3149. 10 indexed citations
9.
Liu, Rongfeng, Junyan Wang, Ming Ma, et al.. (2021). IFN-α, IFN-γ, IL-2 combined with TNF-α for predicting efficacy of PD-1 inhibitors combination therapy in patients with solid cancers.. Journal of Clinical Oncology. 39(15_suppl). 2584–2584. 2 indexed citations
10.
Liu, Rongfeng, Yanzhao Xu, Xing Li, et al.. (2020). Blockade of TRIM59 enhances esophageal cancer cell chemosensitivity to cisplatin by upregulating p53. Oncology Letters. 21(1). 1–1. 9 indexed citations
11.
Guo, Shuqi, Rongfeng Liu, Wei Wang, et al.. (2020). Designing an Artificial Pathway for the Biosynthesis of a Novel Phenazine N-Oxide in Pseudomonas chlororaphis HT66. ACS Synthetic Biology. 9(4). 883–892. 32 indexed citations
12.
Tao, Hongru, Jun Wang, Wenchao Lu, et al.. (2019). Discovery of trisubstituted nicotinonitrile derivatives as novel human GCN5 inhibitors through AlphaScreen-based high throughput screening. RSC Advances. 9(9). 4917–4924. 8 indexed citations
13.
Zhang, Dan, Jie Han, Wenchao Lu, et al.. (2019). Discovery of alkoxy benzamide derivatives as novel BPTF bromodomain inhibitors via structure-based virtual screening. Bioorganic Chemistry. 86. 494–500. 13 indexed citations
14.
Zhou, Chen, Rongfeng Liu, Qihua Zhu, et al.. (2018). Optimization of 5-arylidene barbiturates as potent, selective, reversible LSD1 inhibitors for the treatment of acute promyelocytic leukemia. Bioorganic & Medicinal Chemistry. 26(17). 4871–4880. 15 indexed citations
15.
Liu, Rongfeng, Yu‐Chih Liu, Junwei Meng, Haiyan Zhu, & Xuehong Zhang. (2017). A microfluidics-based mobility shift assay to identify new inhibitors of β-secretase for Alzheimer’s disease. Analytical and Bioanalytical Chemistry. 409(28). 6635–6642. 12 indexed citations
16.
Xing, Jing, Wenchao Lu, Rongfeng Liu, et al.. (2017). Machine-Learning-Assisted Approach for Discovering Novel Inhibitors Targeting Bromodomain-Containing Protein 4. Journal of Chemical Information and Modeling. 57(7). 1677–1690. 39 indexed citations
17.
Hu, Jianping, Xin Wang, Lin Chen, et al.. (2016). Design and discovery of new pyrimidine coupled nitrogen aromatic rings as chelating groups of JMJD3 inhibitors. Bioorganic & Medicinal Chemistry Letters. 26(3). 721–725. 16 indexed citations
18.
Hu, Junchi, Hong Ding, Limin Chen, et al.. (2016). Identification of novel EZH2 inhibitors through pharmacophore-based virtual screening and biological assays. Bioorganic & Medicinal Chemistry Letters. 26(15). 3813–3817. 17 indexed citations
19.
Meng, Fanwang, Hong Ding, Shien Liu, et al.. (2015). Discovery and Optimization of Novel, Selective Histone Methyltransferase SET7 Inhibitors by Pharmacophore- and Docking-Based Virtual Screening. Journal of Medicinal Chemistry. 58(20). 8166–8181. 54 indexed citations
20.
Shen, Jie, Qing Wang, Juan Wang, et al.. (2015). Analysis of soluble urokinase plasminogen activator receptor in multiple myeloma for predicting prognosis. Oncology Letters. 10(4). 2403–2409. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vivek Kumar Singh Breakdown of academic impact, for papers by Junichi Taira Breakdown of academic impact, for papers by Meijuan Huang Breakdown of academic impact, for papers by Xiuhua Wu Breakdown of academic impact, for papers by Byung Ju Kim Breakdown of academic impact, for papers by José Navarro‐Fernández Breakdown of academic impact, for papers by Dexuan Yang Breakdown of academic impact, for papers by Carina Danchik Breakdown of academic impact, for papers by Ana Marı́a Zarate Breakdown of academic impact, for papers by Michael Plewe
Rankless by CCL
2026